UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B

Journal of viral hepatitis, 2003-07, Vol.10 (4), p.298-305

2003

Volltextzugriff (PDF)

Effect of interferon-α on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study

The Lancet (British edition), 1998-05, Vol.351 (9115), p.1535-1539

1998

Volltextzugriff (PDF)

Assessing farm sustainability with the IDEA method - from the concept of agriculture sustainability to case studies on farms

Sustainable development (Bradford, West Yorkshire, England), 2008-07, Vol.16 (4), p.271-281

2008

Volltextzugriff (PDF)

AgriBMPWater: systems approach to environmentally acceptable farming

Environmental modelling & software : with environment data news, 2005-02, Vol.20 (2), p.187-196

2005

Volltextzugriff (PDF)

Peginterferon α-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B

Journal of viral hepatitis, 2003-07, Vol.10 (4), p.298-305

2003

Volltextzugriff (PDF)

Mobiliser des indicateurs pour évaluer les effets propres des mesures agro-environnementales en France

Revue d'économie régionale et urbaine (ADICUEER (Association)), 2010, Vol.juin (3), p.439-471

2010

Volltextzugriff (PDF)

The use of indicators for sustainable development

Sustainable development (Bradford, West Yorkshire, England), 2008-07, Vol.16 (4), p.237-240

2008

Volltextzugriff (PDF)

Retreatment of chronic hepatitis B e antigen–positive patients with recombinant interferon alfa‐2a

Hepatology (Baltimore, Md.), 1999-07, Vol.30 (1), p.277-282

1999

Volltextzugriff (PDF)

Chronic hepatitis C: Interferon retreatment of relapsers. A meta‐analysis of individual patient data

Hepatology (Baltimore, Md.), 1999-09, Vol.30 (3), p.801-807

1999

Volltextzugriff (PDF)

In vitro effect of amantadine and interferon α-2a on hepatitis C virus markers in cultured peripheral blood mononuclear cells from hepatitis C virus-infected patients

Antiviral research, 1999-05, Vol.42 (1), p.59-70

1999

Volltextzugriff (PDF)

Assessing the cost, effectiveness and acceptability of best management farming practices: a pluri-disciplinary approach

International journal of agricultural resources, governance and ecology, 2006, Vol.5 (2/3), p.272

2006

Volltextzugriff (PDF)

421 A new bio-mathematical model to describe the dynamics of HBV-DNA and infected hepatocytes in HBEAG-negative/anti-HBE-positive chronic hepatitis B patients treated with peginterferon alfa-2A (40KD) (PEGASYS®), lamivudine, or PEGASYS® plus lamivudine combin

Journal of hepatology, 2004, Vol.40, p.125-125

2004

Volltextzugriff (PDF)

In vitro effect of amantadine and interferon alpha-2a on hepatitis C virus markers in cultured peripheral blood mononuclear cells from hepatitis C virus-infected patients

Antiviral research, 1999-05, Vol.42 (1), p.59-70

1999

Volltextzugriff (PDF)

Antiviral activity of ganciclovir, 9-(1,3-dihydroxy-2-propoxymethyl) guanine against woodchuck hepatitis virus: quantitative measurement of woodchuck hepatitis virus DNA using storage phosphor technology

Italian journal of gastroenterology and hepatology, 1998-10, Vol.30 (5), p.510

1998

Volltextzugriff (PDF)

Continuous versus intermittent therapy for chronic hepatitis C with recombinant interferon alfa-2a

Gastroenterology (New York, N.Y. 1943), 1994-08, Vol.107 (2), p.479-485

1994

Volltextzugriff (PDF)

Viral hepatitis and its treatment. Present and future

Journal of hepatology, 1991, Vol.13 Suppl 4, p.S163

Zahm, F E

1991

Volltextzugriff (PDF)

Treatment of woodchuck hepatitis virus infection in vivo with 2',-3'-dideoxycytidine (ddC) and 2',-3'-dideoxycytidine monophosphate coupled to lactosaminated human serum albumin (L-HSA ddCMP)

Liver (Copenhagen), 1996-04, Vol.16 (2), p.88-93

1996

Volltextzugriff (PDF)

Chronic hepatitis C: interferon retreatment of relapsers. A meta-analysis of individual patient data. European Concerted Action on Viral Hepatitis (EUROHEP)

Hepatology (Baltimore, Md.), 1999-09, Vol.30 (3), p.801-807

1999

Volltextzugriff (PDF)

Sustained response to interferon- alpha 2a monotherapy of young blood donors with minimal-to-mild chronic hepatitis C

Journal of viral hepatitis, 2000-09, Vol.7 (5), p.352-360

2000

Volltextzugriff (PDF)

Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP)

Hepatology (Baltimore, Md.), 1999-07, Vol.30 (1), p.277-282

1999

Volltextzugriff (PDF)

Sustained response to interferon-alpha2a monotherapy of young blood donors with minimal-to-mild chronic hepatitis C. The Donor Surveillance Study Group

Journal of viral hepatitis, 2000-09, Vol.7 (5), p.352-360

2000

Volltextzugriff (PDF)

Long-term titrated recombinant interferon-α2a in chronic hepatitis C: a randomized controlled trial

Journal of viral hepatitis, 1995-03, Vol.2 (2), p.73-76

1995

Volltextzugriff (PDF)

ATMOSPHERIC FRICTION AS AN OBSTACLE IN LOCOMOTION

Scientific American, 1905-07, Vol.93 (4), p.70-71

ZAHM, A. F.

1905

Volltextzugriff (PDF)

Long-term titrated recombinant interferon-alpha 2a in chronic hepatitis C: a randomized controlled trial

Journal of viral hepatitis, 1995, Vol.2 (2), p.73-76

1995

Volltextzugriff (PDF)

1 – 25 von 241

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(194)
Mit Volltextzugriff
(179)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(124)
Humans
(97)
Life Sciences & Biomedicine
(95)
Female
(60)
Male
(59)
Biological And Medical Sciences
(52)
Adult
(48)
Middle Aged
(47)
Medical Sciences
(44)
Public, Environmental & Occupational Health
(42)
Aged
(32)
Oncology
(31)
Risk Factors
(30)
Animals
(24)
Science & Technology - Other Topics
(24)
Multidisciplinary Sciences
(22)
Cancer
(20)
Pesticides
(18)
Case-Control Studies
(17)
Tumors
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B

Effect of interferon-α on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study

Assessing farm sustainability with the IDEA method - from the concept of agriculture sustainability to case studies on farms

AgriBMPWater: systems approach to environmentally acceptable farming

Peginterferon α-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B

Mobiliser des indicateurs pour évaluer les effets propres des mesures agro-environnementales en France

The use of indicators for sustainable development

Retreatment of chronic hepatitis B e antigen–positive patients with recombinant interferon alfa‐2a

Chronic hepatitis C: Interferon retreatment of relapsers. A meta‐analysis of individual patient data

In vitro effect of amantadine and interferon α-2a on hepatitis C virus markers in cultured peripheral blood mononuclear cells from hepatitis C virus-infected patients

Assessing the cost, effectiveness and acceptability of best management farming practices: a pluri-disciplinary approach

Design and Characterization of R1626, A Prodrug of the HCV Replication Inhibitor R1479 (4′-Azidocytidine) With Enhanced Oral Bioavailability

421 A new bio-mathematical model to describe the dynamics of HBV-DNA and infected hepatocytes in HBEAG-negative/anti-HBE-positive chronic hepatitis B patients treated with peginterferon alfa-2A (40KD) (PEGASYS®), lamivudine, or PEGASYS® plus lamivudine combin

In vitro effect of amantadine and interferon alpha-2a on hepatitis C virus markers in cultured peripheral blood mononuclear cells from hepatitis C virus-infected patients

Antiviral activity of ganciclovir, 9-(1,3-dihydroxy-2-propoxymethyl) guanine against woodchuck hepatitis virus: quantitative measurement of woodchuck hepatitis virus DNA using storage phosphor technology

Continuous versus intermittent therapy for chronic hepatitis C with recombinant interferon alfa-2a

Viral hepatitis and its treatment. Present and future

Treatment of woodchuck hepatitis virus infection in vivo with 2',-3'-dideoxycytidine (ddC) and 2',-3'-dideoxycytidine monophosphate coupled to lactosaminated human serum albumin (L-HSA ddCMP)

Chronic hepatitis C: interferon retreatment of relapsers. A meta-analysis of individual patient data. European Concerted Action on Viral Hepatitis (EUROHEP)

Sustained response to interferon- alpha 2a monotherapy of young blood donors with minimal-to-mild chronic hepatitis C

Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP)

Sustained response to interferon-alpha2a monotherapy of young blood donors with minimal-to-mild chronic hepatitis C. The Donor Surveillance Study Group

Long-term titrated recombinant interferon-α2a in chronic hepatitis C: a randomized controlled trial

ATMOSPHERIC FRICTION AS AN OBSTACLE IN LOCOMOTION

Long-term titrated recombinant interferon-alpha 2a in chronic hepatitis C: a randomized controlled trial

Suchergebnisse filtern